职业四象限分析法

Research & Development

Aiming to be the Global Pharma Innovator with Competitive Advantage in Oncology, Daiichi Sankyo will focus our research and development resources on certain disease areas through prioritization, such as oncology and cardiovascular-metabolics. The decision making would be driven by diversified viewpoints based on science and business perspectives from our supreme decision-making body – GEMRAD (Global Executive Meeting of Research and Development), to maximize research outcomes.

Daiichi Sankyo established an R&D system at three pivotal sites (Japan, the U.S. and Europe), where we collaborate closely in all the stages from drug discovery to development and manufacture. Furthermore, we have established R&D locations in key emerging markets, Shanghai and Beijing in China and Gurgaon in India. We expect that the roles of these emerging markets would become more important in the future.

Worldwide R&D Organization

If you want to know more about Daiichi Sankyo's R&D information, please click here.

Who We Are

Daiichi Sankyo is a global pharmaceutical company striving to contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals.
read more ...

职业四象限分析法 彩票工具大全 双色球爱彩人彩票走势图 赌博签到赚钱 极速pk10是正规的吗 17年极速时时开奖 猜大小单双叫什么 2008年上证指数走势图 河北11选5专家推荐号 重庆快乐10分在线投注 3d悠闲山西麻将手机版 张沫凡家是怎么赚钱的 青海快三精准预测号码 七星彩选号技巧及预测 双色球9+1 微信游戏赚钱平台 福建十一选五怎么玩